Device Trial Radar · NCT07872670
Virtual Reality Therapy to Improve Arthroplasty Outcomes
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Mar 5, 2026
Primary completion
Dec 1, 2026
Study completion Dec 1, 2026
Sponsor
- Lead sponsor
- NHS Highland Research, Development and Innovation OrganisationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Healthy Mind
- First posted
- Oct 13, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Virtual reality (VR) has recently emerged as a non-medication-based method to manage anxiety. The patient wears a VR headset and is offered an immersive environment with hypnotic components with sound and imagery in a 3D environment. VR creates an immersive 3D environment and diverts attention away from worrying thoughts (anxiety) and pain and has been found useful to manage minor procedural pain and related anxiety. This is a pilot feasibility trial to evaluate the effectiveness of VR in improving patient related outcomes (PROM) after joint replacement surgery.
Conditions
- Surgical
- Anxiety
- Pain Management
- Joint (Knee or Hip Replacement)
Interventions
Virtual Reality HeadsetDevice
Use of VR Headset for 20 minutes per day, from between 10 and 7 days pre surgery to 30 days post surgery
Blood SamplesDiagnostic test
Blood samples will be collected from 5 participants randomly selected from each arm. Samples will be collected at baseline, day of surgery, 24 hours post surgery, 30 days post surgery and 90 days post surgery
QuestionnairesBehavioral
Baseline and then FU data at 7, 14, 21, 30 and 90 days post-operative will be collected from participants via questionnaires
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of patients who refuse to participate in the studyTime frame: From 10 days pre surgery to 90 days post surgery
- Percentage of participants with complete questionnairesTime frame: From 10 days pre surgery to 90 days post surgery
- Participant VR Headset Use Compliance RateTime frame: From 7 days pre surgery to 30 days post surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Treatment Centre - Highland
Inverness, Highlands, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.